Coeur D'alene, ID1 Active Studies

Ankylosing Spondylitis Clinical Trials in Coeur D'alene, ID

Find 1 actively recruiting ankylosing spondylitis clinical trials in Coeur D'alene, ID. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
1,524
Enrolling

Recruiting Ankylosing Spondylitis Studies in Coeur D'alene

About Ankylosing Spondylitis Clinical Trials in Coeur D'alene

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 1 ankylosing spondylitis clinical trials recruiting participants in Coeur D'alene, ID. These studies are seeking a combined 1,524 participants. Research is being sponsored by Alliance for Clinical Trials in Oncology. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Coeur D'alene — FAQ

Are there ankylosing spondylitis clinical trials in Coeur D'alene?

Yes, there are 1 ankylosing spondylitis clinical trials currently recruiting in Coeur D'alene, ID. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Coeur D'alene?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Coeur D'alene research site will contact you about next steps.

Are clinical trials in Coeur D'alene free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Coeur D'alene studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 1 active trials in Coeur D'alene are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 22, 2026 from ClinicalTrials.gov